GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Net Interest Income (for Banks)

MYNZ (Mainz Biomed NV) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Mainz Biomed NV Business Description

Traded in Other Exchanges
N/A
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.